View Enduring Content

Right Plase, at the Right Time

Activity Details
  • Credit Amounts:
    • CME: 1.00
    • Other: 1.00
  • Cost: Free
  • Release: Jan 22, 2021
  • Expires: Jan 21, 2024
  • Estimated Time to Complete:
    1 Hour(s)
  • Average User Rating:
    ( Ratings)

Faculty

Jessica D.  Lee Jessica D. Lee, MD, FAAN, FANA
Professor & Vice Chair for Quality, Dept. of Neurology - UK HealthCare
Medical Director, UK Comprehensive Stroke Program
University of Kentucky
Lexington, Kentucky

Needs Statement

This presentation will increase the knowledge of using thrombolytics to treat acute ischemic stroke. Discuss differences between Alteplase and Tenecteplase. Create a better understanding of the 2019 Update to the 2018 Guidelines from the AHA/ASA for the treatment of Acute Ischemic Stroke using IV fibrinolytics.

Target Audience

Physicians, Advanced Practice Providers, Stroke Care and Education Specialists, Nurses, and other healthcare professionals with an interest in stroke care.

Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss the role of intravenous thrombolysis in acute ischemic stroke
  2. Differentiate between currently available thrombolytic agents
  3. Describe the current literature on use of Tenecteplase in acute ischemic stroke
  4. Review 2018 AHA/ASA Guidelines for the Treatment of AIS, and the limitations

Accreditation

Joint Accreditation LogoIn support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA credit: 
This enduring material is designated for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Other
UK Healthcare CECentral certifies this activity for 1 hours of participation.

Faculty Disclosure

No speakers, authors or planners  have any relevant financial relationships to disclose. 

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

In collaboration with UK HealthCare/Norton HealthCare - Stroke Care Network.

Attention: Please Read

The Right Plase, at the Right Time enduring module is a recording from the live meeting 2020 SCN Summit, dated September 28th, October 1st, 2nd and 6th, 2020. If you claimed credit for this session at the live meeting, you should not claim credit for this module.